These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19764841)

  • 61. Analysis of patient satisfaction with a prefilled insulin injection device in patients with type 1 and type 2 diabetes.
    Siegmund T
    J Diabetes Sci Technol; 2011 Sep; 5(5):1235-7. PubMed ID: 22027324
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Injection force of reusable insulin pens: Novopen 4, Lilly Luxura, Berlipen, and ClikSTAR.
    Friedrichs A; Korger V; Adler S
    J Diabetes Sci Technol; 2011 Sep; 5(5):1185-90. PubMed ID: 22027315
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Consensus on Choice of Insulin Pen Devices in Routine Clinical Practice in India.
    Gupta A; Phatak S; Rao YS; Ramesh J; Sanyal D
    Diabetes Technol Ther; 2020 Oct; 22(10):777-786. PubMed ID: 32233934
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Insulin pens for treatment of diabetes].
    Bärtsch U; Comtesse Ch; Wetekam B
    Ther Umsch; 2006 Jun; 63(6):398-404. PubMed ID: 16841576
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Trigger matters: an ergonomy analysis of insulin pens.
    Fendler W; Roman-Liu D; Tokarski T; Romanczuk R; Mlynarski W
    Diabetes Technol Ther; 2015 Mar; 17(3):171-6. PubMed ID: 25607378
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Functional Evaluation of the Reusable JuniorSTAR® Half-Unit Insulin Pen.
    Klonoff D; Nayberg I; Rabbone I; Domenger C; Stauder U; Oualali H; Danne T
    J Diabetes Sci Technol; 2015 May; 9(3):625-31. PubMed ID: 25633967
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of injection force of three insulin delivery pens.
    Asakura T; Seino H; Kageyama M; Yohkoh N
    Expert Opin Pharmacother; 2009 Jun; 10(9):1389-93. PubMed ID: 19466910
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evaluation of dosing and clinical outcomes in patients undergoing conversion of insulin glargine to insulin detemir.
    Bryant GA; McDanel DL; Horner KE; Farris KB; Newkirk EN
    Pharmacotherapy; 2013 Jan; 33(1):56-62. PubMed ID: 23307546
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Insulin pens: the modern delivery devices.
    Baruah MP
    J Assoc Physicians India; 2011 Apr; 59 Suppl():38-40. PubMed ID: 21823254
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The future of basal insulin supplementation.
    Simon AC; DeVries JH
    Diabetes Technol Ther; 2011 Jun; 13 Suppl 1():S103-8. PubMed ID: 21568722
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Solostar pen for glargine and glulisine insulins: line extension. Less convenient than Innolet pen.
    Prescrire Int; 2008 Aug; 17(96):138-9. PubMed ID: 19484849
    [No Abstract]   [Full Text] [Related]  

  • 72. Humalog(®) KwikPen™: an insulin-injecting pen designed for ease of use.
    Schwartz SL; Ignaut DA; Bodie JN
    Expert Rev Med Devices; 2010 Nov; 7(6):735-43. PubMed ID: 21050084
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
    Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
    Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Needle with a novel attachment versus conventional screw-thread needles: a preference and usability test among adults with diabetes and impaired manual dexterity.
    Hansen B; Lilleøre SK; Ter-Borch G
    Diabetes Technol Ther; 2011 May; 13(5):579-85. PubMed ID: 21406015
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Improvement in health-related quality of life, independent of fasting glucose concentration, via insulin pen device in diabetic patients.
    Lee IT; Liu HC; Liau YJ; Lee WJ; Huang CN; Sheu WH
    J Eval Clin Pract; 2009 Aug; 15(4):699-703. PubMed ID: 19674222
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Feasibility of continuous subcutaneous insulin infusion and daily supplemental insulin glargine injection in children with type 1 diabetes.
    Alemzadeh R; Parton EA; Holzum MK
    Diabetes Technol Ther; 2009 Aug; 11(8):481-6. PubMed ID: 19698060
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dose accuracy of the ClikSTAR, NovoPen 4, and Luxura insulin pens: results of laboratory and field studies.
    Friedrichs A; Basso N; Adler S
    J Diabetes Sci Technol; 2011 Sep; 5(5):1179-84. PubMed ID: 22027314
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Evaluation of the injection force dynamics of a modified prefilled insulin pen.
    Rissler J; Jørgensen C; Rye Hansen M; Hansen NA
    Expert Opin Pharmacother; 2008 Sep; 9(13):2217-22. PubMed ID: 18710347
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Insulclock: A Novel Insulin Delivery Optimization and Tracking System.
    Gomez-Peralta F; Abreu C; Gomez-Rodriguez S; Ruiz L
    Diabetes Technol Ther; 2019 Apr; 21(4):209-214. PubMed ID: 30896261
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Nonadherence to Insulin Therapy Detected by Bluetooth-Enabled Pen Cap Is Associated With Poor Glycemic Control.
    Munshi MN; Slyne C; Greenberg JM; Greaves T; Lee A; Carl S; Atakov-Castillo A; Toschi E
    Diabetes Care; 2019 Jun; 42(6):1129-1131. PubMed ID: 30862650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.